On this page
CustomerInsights.AI (CIAI) today announced the launch of ciATHENA®'s Market Mix Modeling (MMM) use case: the pharma industry's first Agentic AI-powered MMM platform, setting new benchmarks for insights, speed, and cost efficiency in life sciences marketing.
Pharma marketers often experience significant delays with traditional MMM, waiting weeks or even months for insights into channel performance, which hinders timely decision-making and action. These slow and retrospective analyses mean that marketers may miss critical market events, such as new payer contracts or competitor product launches, only discovering their impact when it's too late to respond effectively.
Traditional MMM in the pharmaceutical industry struggles with fragmented, hard-to-integrate data, leading to missed market shifts and making it difficult for pharma marketers to adapt strategies in real time.
Purpose-built for Pharma, ciATHENA® MMM redefines Marketing Analytics. The use case generates actionable, persona-driven insights up to 98% faster and at 70% lower costs than traditional approaches, delivering answers in just hours, not months, empowering marketing leaders to act at true market speed.
"We've seen Pharma teams lose millions while waiting for MMM answers that arrive too late. We knew something had to change," said Ankit Chhabra, Chief Product Officer of CIAI. "ciATHENA® MMM empowers marketers to move at the speed of the market, asking questions naturally and getting actionable answers instantly."
ciATHENA® MMM: Self-Service Conversational Intelligence for Pharma Marketers
ciATHENA® MMM is an industry-first use case built to transform marketing and customer engagement decisions at market speed. Users can ask plain-English questions such as "Which channel drove maximum prescription lift this quarter?" and receive contextual, explainable answers instantly. Some of the other key differentiators include:
- Autonomous, conversational answers in plain English
- Real-time adaptability to market triggers
- Intelligent budget simulations for optimization
"ciATHENA® MMM moves commercial teams from justifying the mix to continuously improving it," said Darren Lenczycki, Client Partner, Commercialization Strategy. "Our use case learns, adapts, and tailors its insights for marketers, brand managers, analytics leaders, extending even to enterprise-wide insights, delivering market-ready decisions on demand."
Click here to learn more about the ciATHENA® MMM use case.
About CustomerInsights.AI
CustomerInsights.AI is a platform-led analytics-as-a-service company built exclusively for the life sciences industry. Founded in 2018 by pharma and analytics leaders, the company was built on the belief that AI should become a core operational capability rather than a standalone innovation initiative. CIAI has pioneered a Platform-Led Analytics-as-a-Service (PLAaaS) model, combining technology, deep domain expertise, and AI-driven intelligence to deliver measurable commercial outcomes for life sciences organizations.
Its flagship platforms, ciPARTHENON® and ciATHENA®, help pharmaceutical and biotech organizations modernize analytics ecosystems, reduce operational complexity, and improve commercial decision-making through AI-powered intelligence.
CIAI serves clients ranging from emerging biotech companies to some of the world's leading pharmaceutical organizations through teams across North America and India.
For more information, visit CustomerInsights.AI or follow us on LinkedIn.
